ARCHIVES

FDA Puts Clinical Hold On Gene Therapy Trials

This article is from The Cancer Letter archive.

Vol. 29 No. 04 | January 24, 2003

Download PDF Visit The Full Archive

Related Articles

Greenwald Lists Plans For $40 Million Raise In Prevention & Control

December 3, 1993

DCCR Free Up $5 Million; New Policy Limits Core Support

November 5, 1976

New CIDAC RFP Limits Recompetition To Small Business Firms

January 6, 1984

ODAC Nixes Abraxane for Adjuvant Breast Cancer, While Genasense Falls Victim to Its Randomized Trial.

September 8, 2006

Pennsylvania Cancer Center Gets $100 Million; Watson, Weinberg, Win National Science Medals

December 19, 1997

Drug Approvals: FDA grants accelerated approval for Keytruda in metastatic melanoma

September 5, 2014